Left Ventricular Assist Device in Older Adults

Left ventricular assist devices (LVADs) are an effective therapy for a growing and aging population in the background of limited donor supply. Selecting the proper patient involves assessment of indications, risk factors, scores for overall outcomes, assessment for right ventricular failure, and opt...

Full description

Saved in:
Bibliographic Details
Published inHeart failure clinics Vol. 13; no. 3; p. 619
Main Authors Caraang, Chris, Lanier, Gregg M, Gass, Alan, Aronow, Wilbert S, Gupta, Chhaya Aggarwal
Format Journal Article
LanguageEnglish
Published United States 01.07.2017
Subjects
Age Factors
Aged
Female
Heart Failure - therapy
Heart-Assist Devices
Humans
Heart failure
Left ventricular assist device
Elderly patients
Online AccessGet more information

Cover

More Information
Summary:Left ventricular assist devices (LVADs) are an effective therapy for a growing and aging population in the background of limited donor supply. Selecting the proper patient involves assessment of indications, risk factors, scores for overall outcomes, assessment for right ventricular failure, and optimal timing of implantation. LVAD complications have a 5% to 10% perioperative mortality and complications of bleeding, thrombosis, stroke, infection, right ventricular failure, and device failure. As LVAD engineering technology evolves, so will the risk-prediction scores. Hence, more large-scale prospective data from multicenters will continually be required to aid in patient selection, reduce complications, and improve long-term outcomes.
ISSN:1551-7136
DOI:10.1016/j.hfc.2017.02.013